Velarion Records
Free. Unsubscribe any time.

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. filed 25 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 35 transactions and 381,540 shares. 10 carry the SEC's AFF10B5ONE flag; 15 name a plan only in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Crinetics Pharmaceuticals, Inc. 35

Adoption dates in Crinetics Pharmaceuticals, Inc. 7

Results prints in Crinetics Pharmaceuticals, Inc. 9

Trades before a print in Crinetics Pharmaceuticals, Inc. 3

Interval to Crinetics Pharmaceuticals, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Crinetics Pharmaceuticals, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on May 21, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.